Globe Life raises annual earnings forecast after reporting margin increase in Q2
Reuters2026/07/22 20:27
Overview
U.S. life and health insurer's Q2 net income per share rose 20% yr/yr
Total premium revenue for Q2 grew 7% from a year earlier
Company repurchased 1.1 mln shares for $175 mln during the quarter
Outlook
Globe Life raises full-year 2026 earnings guidance to $15.55-$15.95 per share
Result Drivers
PREMIUM REVENUE GROWTH - Total premium revenue rose 7% yr/yr, with life premium up 3% and health premium up 16%
UNDERWRITING MARGINS - Life and health underwriting margins increased, with Liberty National and Family Heritage divisions reporting double-digit margin growth
AGENT COUNT - Average producing agent count increased 8% at Liberty National and 7% at Family Heritage, supporting higher sales
Company press release: ID:nPn7P3xXMa
Key Details
Metric |
Beat/Miss |
Actual |
Consensus Estimate |
Q2 EPS |
|
$3.65 |
|
Analyst Coverage
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
The average consensus recommendation for the life health insurance peer group is "hold"
Wall Street's median 12-month price target for Globe Life Inc is $192.50, about 4.4% above its July 21 closing price of $184.34
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 9 three months ago
Reuters Recommended Reads
July 21 - Insurer Chubb posts higher second-quarter profit on strong underwriting business
July 20 - W. R. Berkley second-quarter profit rises on strong underwriting
July 21 - Amerisafe Q2 adjusted EPS misses estimates
For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact reuters.support@thomsonreuters.com.
(This story was created using Reuters automation and AI based on LSEG and company data. It was checked and edited by a Reuters journalist prior to publication.)
Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.
You may also like
SNOWFLAKE INC. <SNOW.N>: JEFFERIES RAISES TARGET PRICE TO $385 FROM $310
CBRE GROUP, INC. <CBRE.N>: JEFFERIES RAISES TARGET PRICE TO $180 FROM $170
JLL <JLL.N>: JEFFERIES RAISES TARGET PRICE TO $437 FROM $383
FRANCO-NEVADA CORPORATION <FNV.N>: JEFFERIES RAISES TARGET PRICE TO $256 FROM $230